Infectious Disease Researcher Dr. John H. Powers III Appointed to Lead NIAID
Dr. John H. Powers III has been appointed to lead the National Institute of Allergy and Infectious Diseases, succeeding previous directors amid a period of significant transition for federal health agencies.
🧠AI AnalysisPhoto: The New York Times Health
Key points
- Dr. John H. Powers III takes over as director of NIAID.
- The institute manages a budget of over $6.5 billion and vital infectious disease research.
- The appointment follows recent administrative shifts and a new focus on vaccine safety studies.
Dr. John H. Powers III, an infectious disease researcher and clinical trials design specialist, was appointed on Monday to direct the National Institute of Allergy and Infectious Diseases (NIAID). The position places him at the head of a politically contentious division with a budget exceeding $6.5 billion, overseeing research into critical public health threats including measles and Ebola. His designation follows a rapid rise through government contracting roles and a period of turbulence within federal health leadership.
Since the beginning of the second Trump administration, Dr. Powers has gained prominence among senior health officials, aligning with Health Secretary Robert F. Kennedy Jr.'s priorities regarding vaccine safety research. Prior to his permanent appointment, he helped develop a major research initiative examining health issues following vaccination or infection. During a briefing on Monday, Dr. Powers emphasized that his focus centers on gathering clear evidence regarding where and in which populations vaccines provide a benefit, stating that benefits justify potential harms.
While some supporters and patient advocates praise his attention to rare vaccine side effects and vulnerable populations, the appointment arrives amid broader administrative changes and political scrutiny surrounding federal health research. Past large-scale studies have established no link between vaccines and autism, and Dr. Powers noted that such policy questions remain beyond the remit of the infectious diseases institute.
What to know: Dr. John H. Powers III now leads the National Institute of Allergy and Infectious Diseases, taking over a division with a multi-billion-dollar budget and oversight of major pathogen research. Readers with questions about personal medical decisions, immunizations, or health concerns should consult a qualified healthcare provider.
Source The New York Times Health — nytimes.com/2026/11/16/science/niaid-chief-john-powers.html ↗
Read next
🔬ResearchCBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities
A double-blind clinical trial published in JAMA Pediatrics indicates that CBD oil provides no significant behavioral improvement for children and teenagers with intellect…
🏃FitnessExpert Advice on Hydration Gear Sparks Debate Among Recreational Runners
Olympic medalist Josh Kerr recently suggested that runners may not require hydration packs for distances under 12 miles, igniting a broader conversation about gear necess…
🏃FitnessA Structured Approach to Beginning a Strength and Cardio Routine
A new four-week training program offers beginners a guided path to incorporating strength training and cardiovascular exercise into their daily lives.
🧠Mind & Mental HealthThe Role of Daily Mobility Training in Managing Sedentary Tension
A two-week personal trial suggests that incorporating short, daily mobility exercises may help alleviate stiffness associated with sedentary desk work. Experts note that …
🧠Mind & Mental HealthNew Theoretical Framework Explores Memory Formation and Dementia
Researchers have proposed a new model suggesting the brain's limbic system functions similarly to generative AI, potentially offering a new way to understand and classify…
🏥Public HealthRecall Issued for Generic Propranolol Over Potential Metal Contamination
Breckenridge Pharmaceutical has initiated a voluntary recall of one lot of generic propranolol capsules due to the potential presence of metal fragments.